China Pharma Holdings - 23 Year Stock Price History | CPHI
Historical daily share price chart and data for China Pharma Holdings since 2002 adjusted for splits and dividends. The latest closing stock price for China Pharma Holdings as of June 27, 2025 is 1.83.
- The all-time high China Pharma Holdings stock closing price was 520.50 on October 28, 2003.
- The China Pharma Holdings 52-week high stock price is 2.60, which is 42.1% above the current share price.
- The China Pharma Holdings 52-week low stock price is 0.12, which is 93.4% below the current share price.
- The average China Pharma Holdings stock price for the last 52 weeks is 0.56.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| China Pharma Holdings Historical Annual Stock Price Data |
| Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
| 2025 |
2.0577 |
2.3900 |
2.9490 |
1.3000 |
1.8260 |
-21.46% |
| 2024 |
2.2895 |
1.1670 |
4.2500 |
0.6900 |
2.3250 |
92.15% |
| 2023 |
3.7869 |
8.7000 |
11.6900 |
0.8930 |
1.2100 |
-87.38% |
| 2022 |
25.0124 |
45.8300 |
49.9500 |
9.4851 |
9.5900 |
-80.13% |
| 2021 |
70.7519 |
49.0000 |
128.0000 |
41.0000 |
48.2600 |
8.25% |
| 2020 |
47.7501 |
24.7500 |
114.0000 |
24.7500 |
44.5800 |
88.26% |
| 2019 |
28.3586 |
24.0000 |
50.7000 |
22.2100 |
23.6800 |
-8.00% |
| 2018 |
28.7640 |
17.3000 |
57.9900 |
17.1900 |
25.7400 |
46.58% |
| 2017 |
21.2774 |
25.4200 |
29.0000 |
15.0000 |
17.5600 |
-32.46% |
| 2016 |
21.1852 |
16.4200 |
31.9500 |
12.0000 |
26.0000 |
65.71% |
| 2015 |
28.0154 |
31.0000 |
42.0000 |
15.5800 |
15.6900 |
-47.72% |
| 2014 |
38.5597 |
36.0000 |
78.5000 |
20.5000 |
30.0100 |
-13.01% |
| 2013 |
27.0134 |
26.0000 |
47.0000 |
19.0100 |
34.5000 |
70.79% |
| 2012 |
45.1813 |
67.6000 |
82.0000 |
19.0000 |
20.2000 |
-69.85% |
| 2011 |
198.1828 |
311.0000 |
313.0000 |
67.0000 |
67.0000 |
-77.89% |
| 2010 |
307.0487 |
375.0000 |
412.0000 |
213.0000 |
303.0000 |
-21.30% |
| 2009 |
211.1875 |
117.0000 |
393.0000 |
113.0000 |
385.0000 |
237.72% |
| 2008 |
209.0905 |
295.0000 |
309.0000 |
110.0000 |
114.0000 |
-62.62% |
| 2007 |
213.7187 |
225.0000 |
417.0000 |
135.0000 |
305.0000 |
34.36% |
| 2006 |
148.8547 |
180.0000 |
235.0000 |
105.0000 |
227.0000 |
26.11% |
| 2005 |
168.8066 |
40.0000 |
265.0000 |
35.0000 |
180.0000 |
350.00% |
| 2004 |
109.9565 |
200.0000 |
200.0000 |
40.0000 |
40.0000 |
-86.67% |
| 2003 |
288.8825 |
51.0000 |
520.5000 |
7.0000 |
300.0000 |
2400.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.006B |
$0.005B |
|
CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings.
|
